7Baggers
 BioCryst (BCRX) Grants Stock Options and RSUs to New Employees  GuruFocus Fri, 03 Oct 2025 11:44:59 GMT
 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  The Manila Times Fri, 03 Oct 2025 11:13:16 GMT
 BioCryst Pharmaceuticals Enters Oversold Territory (BCRX)  Nasdaq Thu, 02 Oct 2025 16:53:00 GMT
 Biocryst sells European rights to HAE therapy Orladeyo for $250M  Angioedema News Thu, 02 Oct 2025 15:00:00 GMT
 BioCryst completes sale of European ORLADEYO business for $250M  TipRanks Wed, 01 Oct 2025 14:45:55 GMT
 BioCryst Sells European ORLADEYO Business for $250M  TipRanks Wed, 01 Oct 2025 12:32:03 GMT
 BioCryst (BCRX) Finalizes European ORLADEYO Business Sale  GuruFocus Wed, 01 Oct 2025 12:27:38 GMT
 Biocryst completes sale of European Orladeyo (berotralstat) business  MarketScreener Wed, 01 Oct 2025 11:26:34 GMT
 BioCryst Pharma stock downgraded by Evercore ISI amid HAE competition  Investing.com Wed, 01 Oct 2025 11:24:00 GMT
 BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business  GlobeNewswire Wed, 01 Oct 2025 11:03:35 GMT
 BioCryst: Blue Light Special In Small-Cap Biotech Aisle (NASDAQ:BCRX)  Seeking Alpha Mon, 29 Sep 2025 06:53:43 GMT
 ionis targets ultra-rare disease market with zilganersen  insights.citeline.com Mon, 22 Sep 2025 20:38:03 GMT
 published on: 2025-09-04 04:25:22  Newser Thu, 04 Sep 2025 09:25:22 GMT
 published on: 2025-09-01 00:02:12  Newser Mon, 01 Sep 2025 05:02:12 GMT
 published on: 2025-08-31 13:57:41  Newser Sun, 31 Aug 2025 18:57:41 GMT
 published on: 2025-08-31 12:26:45  Newser Sun, 31 Aug 2025 17:26:45 GMT
 published on: 2025-08-29 13:33:35  Newser Fri, 29 Aug 2025 18:33:35 GMT
 published on: 2025-08-28 22:05:03  Newser Fri, 29 Aug 2025 03:05:03 GMT
 published on: 2025-08-28 20:05:01  Newser Fri, 29 Aug 2025 01:05:01 GMT

BioCryst Pharmaceuticals, Inc
(NASDAQ:BCRX) 

BCRX stock logo

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; Mundesine, an ora...

Founded: 1986
Full Time Employees: 140
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends